Sneaky new trend companies are using to target GLP-1 and other weight-loss drug users

While the nutritional needs of GLP-1 users are not drastically different from the general population, according to a ...

Plan to include pregnant women in drug trials ‘a generational change’

The World Health Organisation will this year start to work with scientists and drug developers to gather more information ...

US FDA requests removal of suicide warnings from weight-loss drug labels

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
WKYC3

Tuesday's Daily Dose: New libido drug, changes in supplement labels and study of nail fungus

CLEVELAND — The Food and Drug Administration has approved expanded use of Addyi, a medication designed to address low sexual desire in women, now including post-menopausal women under age 65. Sprout ...
MarketWatch

AstraZeneca, Daiichi Sankyo Drug Gets U.S. Nod for Breast-Cancer Label Expansion

AstraZeneca and Daiichi Sankyo got U.S. approval to expand the label of their jointly developed Enhertu drug in combination with another medicine as an initial treatment for a type of breast cancer.